Executive Summary
The market state
Thailand's private hospitals earned THB 322 bn in 2024, up about 4% [ttb analytics 2024], with sector spend set to grow at a 6.1% CAGR toward THB 427 bn by 2029 [Sector Outlook 2025]. Domestic volume is approaching saturation; the differentiated growth sits in foreign patients — roughly THB 57 bn, expanding 8–10% [ttb analytics 2024] — and in higher-acuity, higher-margin care.
Why now: a forced redesign
Three forces converge. Thais aged 60+ reached 13.6 m, or 20% of the population, in 2024 [GISTDA 2025], heading for 28% by 2035 [WHO 2024]. Medical inflation runs ahead of GDP, and a doctor density of just 1 per 2,000 [SCMP 2024] caps capacity. The chains cannot grow on bed volume alone, so they redesign the offer toward premium long-stay, wellness, and regional reach.
Ageing and acuity, not headcount, drive the next leg
Private hospitals are forecast to serve 2.7 m inpatients and 21.0 m outpatients in 2024, rising to 2.9 m and 26.3 m by 2030 [Sector Outlook 2025]. Outpatient volume grows fastest, but revenue concentrates in the ageing, chronically ill cohort that fills premium beds.
An ageing demand base
Thais aged 65+ are projected to reach 21% of the population by 2030 [Sector Outlook 2025]. Non-communicable diseases — diabetes, cardiac, oncology — drive longer admissions and higher acuity, the segments where private chains earn the most per bed-day.
Foreign patients rebuild faster
Foreign-patient revenue across private hospitals reached roughly THB 57 bn in 2024, up 8–10% [ttb analytics 2024], outpacing the ~4% domestic pace. The rebuild is concentrating in Gulf, CLMV, and Chinese source markets.
The capacity ceiling
System demand is set to rise by 40.5 m visits in 2026 [Nation 2025] against a doctor density of 1 per 2,000 [SCMP 2024]. Capacity, not appetite, is the constraint that forces the redesign.